GluN2B-Containg NMDA Receptors on Adult-Born Granule Cells Contribute to the Antidepressant Action of Fluoxetine

Ablation of adult neurogenesis in mice has revealed that young adult-born granule cells (abGCs) are required for some of the behavioral responses to antidepressants (ADs), yet the mechanism by which abGCs contribute to AD action remains unknown. During their maturation process, these immature neuron...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neuroscience Vol. 10; p. 242
Main Authors Tannenholz, Lindsay, Hen, René, Kheirbek, Mazen A
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 31.05.2016
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ablation of adult neurogenesis in mice has revealed that young adult-born granule cells (abGCs) are required for some of the behavioral responses to antidepressants (ADs), yet the mechanism by which abGCs contribute to AD action remains unknown. During their maturation process, these immature neurons exhibit unique properties that could underlie their ability to influence behavioral output. In particular, abGCs in the DG exhibit a period of heightened plasticity 4-6 weeks after birth that is mediated by GluN2B-expressing NMDA receptors. The functional contribution of this critical window to AD responsiveness is unclear. Here, we determined the behavioral and neurogenic responses to the AD fluoxetine (FLX) in mice lacking GluN2B-containing NMDA receptors in abGCs. We found that these mice exhibited an attenuated response to FLX in a neurogenesis-dependent behavioral assay of FLX action, while neurogenesis-independent behaviors were unaffected by GluN2B deletion. In addition, deletion of GluN2B attenuated FLX-induced increases in dendritic complexity of abGCs suggesting that the blunted behavioral efficacy of FLX may be caused by impaired differentiation of young abGCs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Neurogenesis, a section of the journal Frontiers in Neuroscience
Reviewed by: Joshua Breunig, Cedars-Sinai Medical Center, USA; Alexey Terskikh, Sanford-Burnham Medical Research Institute, USA
Edited by: Grigori Enikolopov, Stony Brook University, USA
ISSN:1662-4548
1662-453X
1662-453X
DOI:10.3389/fnins.2016.00242